Literature DB >> 28976690

The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury.

Ronald G Thurman1, Blair U Bradford1, Yuji Iimuro1, Kathryn T Knecht1, Gavin E Arteel1, Ming Yin1, Henry D Connor1,2, Chantal Wall1, James A Raleigh3, Moritz V Frankenberg1, Yukito Adachi1, Donald T Forman4, David Brenner5, Maria Kadiiska2, Ronald P Mason2.   

Abstract

Previous research from this laboratory using a continuous enteral ethanol (EtOH) administration model demonstrated that Kupffer cells are pivotal in the development of EtOH-induced liver injury. When Kupffer cells were destroyed using gadolinium chloride (GdCl3 ) or the gut was sterilized with polymyxin B and neomycin, early inflammation due to EtOH was blocked. Anti-tumour necrosis factor (TNF)-α antibody markedly decreased EtOH-induced liver injury and increased TNF-mRNA. These findings led to the hypothesis that EtOH-induced liver injury involves increases in circulating endotoxin leading to activation of Kupffer cells. Pimonidazole, a nitro-imidazole marker, was used to detect hypoxia in downstream pericentral regions of the lobule. Following one large dose of EtOH or chronic enteral EtOH for 1 month, pimonidazole binding was increased significantly in pericentral regions of the liver lobule, which was diminished with GdCl3 . Enteral EtOH increased free radical generation detected with electron spin resonance (ESR). These radical species had coupling constants matching α-hydroxyethyl radical and were shown conclusively to arise from EtOH based on a doubling of the ESR lines when 13 C-EtOH was given. α-Hydroxyethyl radical production was also blocked by the destruction of Kupffer cells with GdCl3 . It is known that females develop more severe EtOH-induced liver injury more rapidly and with less EtOH than males. Female rats on the enteral protocol exhibited more rapid injury and more widespread fatty changes over a larger portion of the liver lobule than males. Plasma endotoxin, ICAM-1, free radical adducts, infiltrating neutrophils and transcription factor NFκB were approximately two-fold greater in livers from females than males after 4 weeks of enteral EtOH treatment. Furthermore, oestrogen treatment increased the sensitivity of Kupffer cells to endotoxin. These data are consistent with the hypothesis that Kupffer cells participate in important gender differences in liver injury caused by ethanol. © 1998 The Official Publication of the Asian Pacific Association for the Study of the Liver and the Asian Pacific Association of Gastroenterology.

Entities:  

Keywords:  Kupffer cells; endotoxin; ethanol; free radicals; hypoxia; liver injury

Year:  1998        PMID: 28976690     DOI: 10.1111/jgh.1998.13.s1.39

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1/p38MAPKα-dependent mechanisms.

Authors:  Jing Ma; Haixia Cao; Robim M Rodrigues; Mingjiang Xu; Tianyi Ren; Yong He; Seonghwan Hwang; Dechun Feng; Ruixue Ren; Peixin Yang; Suthat Liangpunsakul; Jian Sun; Bin Gao
Journal:  JCI Insight       Date:  2020-07-23

Review 2.  "Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders.

Authors:  Leszek Rudzki; Agata Szulc
Journal:  Front Psychiatry       Date:  2018-05-29       Impact factor: 4.157

3.  Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression.

Authors:  Yang Zhao; Yan Cai; Li-Yan Cui; Wen Tang; Bo Liu; Jia-Jia Zheng; Wen-Zhe Si; Xian Wang; Ming-Jiang Xu
Journal:  Oxid Med Cell Longev       Date:  2019-03-17       Impact factor: 6.543

Review 4.  Recent Advances in Models of Immune-Mediated Drug-Induced Liver Injury.

Authors:  Farah Tasnim; Xiaozhong Huang; Christopher Zhe Wei Lee; Florent Ginhoux; Hanry Yu
Journal:  Front Toxicol       Date:  2021-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.